Sign in
4

Changes in Ownership

Oric Pharmaceuticals, Inc. Filed Acc 0001209191-21-029379

Director sold 200 shares at an average $25.17 ($5,034)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Heyman Richard A. Director 2021-04-28 Sale −100 $25.08 $2,508 227,300 I: show line 1 in the form
Heyman Richard A. Director 2021-04-30 Sale −100 $25.26 $2,526 227,200 I: show line 2 in the form
Open-market sales · 200 sh · avg $25.17 · $5,034
Loading xslF345X03/doc4.xml…